Number of the records: 1
Quinazoline derivatives used to treat HIV
- 1.
SYSNO ASEP 0547788 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Quinazoline derivatives used to treat HIV Author(s) Jansa, Petr (UOCHB-X) RID
Šimon, Petr (UOCHB-X) ORCID
Lansdon, E. (US)
Hu, Y. E. (US)
Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
Dejmek, Milan (UOCHB-X) RID, ORCID
Mackman, R. (US)Year of issue 2021 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. EP3521282 Date of the patent acceptance 25.08.2021 Name of the patent owner Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name EPO_1 - European Patent Office Munich, The Hague, Berlin, Vienna, Brusselshttp://www.epo.org/ Current use B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem Language eng - English Keywords reverse transcriptase ; reverse transcriptase ; antiviral ; NNRTI OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210825&DB=&locale=en_EP&CC=EP&NR=3521282B1&KC=B1&ND=4
Number of the records: 1